ERBB2 and neoplasm: Moreover, we engrafted triple-negative (MDA-MB-231) and Her2-positive (BT-474, SK-BR-3, and JIMT-1) cell lines in immunocompromised and in humanized tumor mice to assess the potential impact human immune cells on the PD-L1 expression in vivo.